A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2011
08/04/2011	US20110189129 Hepatitis c virus inhibitors
08/04/2011	US20110189128 Recombinant super-compound interferon
08/04/2011	US20110189127 Tricyclic indole derivatives and methods of use thereof
08/04/2011	US20110189126 Compositions containing interleukin-1 and peptides
08/04/2011	US20110189125 Modulators of HSP70/DnaK Function and Methods of Use Thereof
08/04/2011	US20110189124 Methods for refolding proteins containing free cysteine residues
08/04/2011	US20110189123 Mammalian cx3c chemokine antibodies
08/04/2011	US20110189120 Aegyptin and uses thereof
08/04/2011	US20110189105 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use
08/04/2011	US20110189104 Surfactant protein d for the treatment of disorders associated with lung injury
08/04/2011	US20110189097 Use of WNT inhibitor to inhibit angiogenesis in the CNS
08/04/2011	US20110189095 Crkl targeting peptides
08/04/2011	US20110189085 Antibody Therapy
08/04/2011	US20110189084 Method for Treating Liver Disorders with Receptor Associated Protein (RAP) Peptide-Fucosidase Inhibitor Conjugates
08/04/2011	US20110189083 Dock-and-Lock (DNL) Vaccines for Cancer Therapy
08/04/2011	CA2788726A1 Oligopeptidic compounds and uses thereof
08/04/2011	CA2788304A1 Glucagon antagonist - gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity
08/04/2011	CA2788175A1 Method for treating liver disorders with receptor associated protein (rap) peptide-fucosidase inhibitor conjugates
08/04/2011	CA2788021A1 Pro-angiogenic fragments of prominin-1 and uses thereof
08/04/2011	CA2787940A1 Engineered polypeptide agents for targeted broad spectrum influenza neutralization
08/04/2011	CA2787832A1 Polynucleotide encoding acyl-coa synthetase homolog and method and use thereof
08/04/2011	CA2786621A1 Methods of treating glucose metabolism disorders
08/03/2011	EP2351855A1 RNA aptamers and methods for identifying the same
08/03/2011	EP2351852A1 RNA interference mediating small RNA molecules
08/03/2011	EP2351844A1 Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells
08/03/2011	EP2351840A1 Polypeptides involved in immune response
08/03/2011	EP2351838A1 Crosslinking agonistic antibodies
08/03/2011	EP2351777A1 Anti-muc1 antibody
08/03/2011	EP2351776A1 Oxyntomodulin analogues and their effects on feeding behaviour
08/03/2011	EP2351772A1 Proteins and nucleic acids from meningitis/sepsis-associated Escherichia coli
08/03/2011	EP2351771A1 Immunosuppressive peptide
08/03/2011	EP2351769A2 Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom
08/03/2011	EP2351767A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/03/2011	EP2351765A2 Oligonucleotide-containing pharmacological compositions and their use
08/03/2011	EP2351586A1 Pharmaceutical compositions of active polypeptides for enhanced pharmacological activity through oral and parenteral administration
08/03/2011	EP2351575A2 Novel uses of grs proteins or fragments thereof
08/03/2011	EP2351574A1 Promoter for regeneration of tendon-bone junction tissue or ligament-bone junction tissue
08/03/2011	EP2351573A1 Neuregulin in the treatment of heart diseases
08/03/2011	EP2351563A1 Agent for treatment of diabetes
08/03/2011	EP2350641A1 Method of treatment
08/03/2011	EP2350305A1 Combination treatments comprising protease binding proteins for inflammatory disorders
08/03/2011	EP2350273A2 Compositions of engineered human arginases and methods for treating cancer
08/03/2011	EP2350267A1 Production of products of pharmaceutical interest in plant cell cultures
08/03/2011	EP2350264A2 Treatment of chronic inflammatory respiratory disorders
08/03/2011	EP2350125A1 Hla-g polypeptides and pharmaceutical uses thereof
08/03/2011	EP2350124A1 Il-29 mutants and uses thereof
08/03/2011	EP2350121A1 Anti-apoptotic fusion proteins
08/03/2011	EP2350119A1 Lipopeptide compounds and their use
08/03/2011	EP2350117A1 Peptide derivatives and use thereof as carriers for molecules in the form of conjugates
08/03/2011	EP2350116A1 Treatment of biofilms
08/03/2011	EP2350114A1 Cyclic carboxamide compounds and analogues thereof as of hepatitis c virus
08/03/2011	EP2350112A2 Site-specific n-terminal modifications of proteins and conjugate formation
08/03/2011	EP2350096A1 Methods of treating hepatic encephalopathy
08/03/2011	EP2349485A1 Drug for treating infections
08/03/2011	EP2349454A1 Facilitation of resuscitation from cardiac arrest by erythropoietin
08/03/2011	EP2349348A2 Compositions and methods for reducing the signs of aging of the skin
08/03/2011	EP2349333A1 Mimotopes of hiv env
08/03/2011	EP2349332A2 Methods and compositions for regulating iron homeostasis by modulation bmp-6
08/03/2011	EP2349326A2 A new pharmaceutical product
08/03/2011	EP2349325A2 Protecting and repairing cartilage and musculoskeletal soft tissues
08/03/2011	EP2349324A2 Combination of an insulin and a glp-1 agonist
08/03/2011	EP2349323A2 Methods of using corticotropin-releasing factor for the treatment of cancer
08/03/2011	EP2349322A1 Stable, water-insoluble r-(+)-alpha-lipoic acid salt useful for the treatment of diabetes mellitus and its co-morbidities
08/03/2011	EP2349321A1 Annexin and its use to treat inflammatory disorders
08/03/2011	EP2349320A1 Compositions and methods for treatment of kidney disorders
08/03/2011	EP2349319A1 Cosmetic and therapeutic use of proteins of dj-1 type for treating skin dryness
08/03/2011	EP2349318A1 Antibiotic synergism
08/03/2011	EP2349317A2 Treatment of intracellular bacterial infections
08/03/2011	EP2349316A1 Phosphopeptide enrichment of compositions by fractionation on ceramic hydroxyapatite
08/03/2011	EP2349315A1 Regulation of lymphocytes and uses therefor
08/03/2011	EP2349314A2 Lyophilized recombinant vwf formulations
08/03/2011	EP2349313A1 Combination therapy with peptide epoxyketones
08/03/2011	EP2349312A2 N-terminally modified tetrapeptide derivatives having a c-terminal arginine mimetic
08/03/2011	EP2349311A1 Compositions and methods for treatment of radiation exposure
08/03/2011	EP2349310A1 Polypeptide for treating or preventing adhesions
08/03/2011	EP2349309A1 Pyrazalone derivative formulations
08/03/2011	EP2349308A1 Compounds for treatment of alzheimer's disease
08/03/2011	EP2349307A1 Process for making bivalirudin
08/03/2011	EP2349306A1 Active agents, compositions, and methods for inhibiting and reversing platelet function
08/03/2011	EP2349305A1 Phytochemical compositions and methods for activating amp-kinase
08/03/2011	EP2349291A2 Agonists of toll-like receptor 5 for the treatment of graft-versus-host disease
08/03/2011	EP2349286A2 Method for apcdd1 mediated regulation of hair growth and pigmentation and mutants thereof
08/03/2011	EP2349244A1 Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof
08/03/2011	EP2349224A1 Orally administrable immunostimulant product for aquaculture
08/03/2011	EP2349200A1 Highly concentrated drug particles, formulations, suspensions and uses thereof
08/03/2011	EP2211892B1 Compositions comprising myelin basic protein peptides and medical uses thereof
08/03/2011	EP1692265B1 Method of preventing virus: cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins
08/03/2011	EP1620132B1 Biological pacemaker
08/03/2011	EP1317282B1 Vectors for molecule delivery to cd11b expressing cells
08/03/2011	EP1212055B1 Neurotherapeutic composition comprising a beta-lactam compound
08/03/2011	EP1078092B1 Expression vectors for stimulating an immune response and methods of using the same
08/03/2011	CN1878871B IL-1 receptor based antagonists and methods of making and using
08/03/2011	CN1846793B Tissue engineering bone and its construction and application
08/03/2011	CN102143978A Anti- P2X7 peptides and epitopes
08/03/2011	CN102143970A Peptide analogs of alpha-melanocyte stimulating hormone
08/03/2011	CN102143759A New protecting compositions for recombinantly produced factor viii
08/03/2011	CN102143758A FGF21 mutants and uses thereof
08/03/2011	CN102143757A Chimeric natriuretic polypeptides and methods for inhibiting cardiac remodeling
08/03/2011	CN102143755A Methods and means for soft tissue engineering
08/03/2011	CN102143686A Durable treatment with 4-aminopyridine in patients with demyelination

1 ... 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 ... 3163